In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature

BACKGROUND: Epidermal growth factor receptor variant III (EGFRvIII) is a driver mutation and potential therapeutic target in glioblastoma. Non-invasive in vivo EGFRvIII determination, using clinically acquired multiparametric MRI sequences, could assist in assessing spatial heterogeneity related to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Akbari, Hamed, Bakas, Spyridon, Pisapia, Jared M, Nasrallah, MacLean P, Rozycki, Martin, Martinez-Lage, Maria, Morrissette, Jennifer J D, Dahmane, Nadia, O’Rourke, Donald M, Davatzikos, Christos
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Basic and Translational Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280148/
https://ncbi.nlm.nih.gov/pubmed/29617843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi